pharmacontrol pharo acquire revco unit pharmacontrol acquire private formulation revco million dollar cash dlr promissory note warrant buy pharmacontrol common share pharmacontrol purchase price finance million dollar capital secure institutional finance company betweenm dollar dollar principal amount revco note plus accrue payable june balance payable pharmacontrol expect payment due revco proceed propose offer unit consist convertible subordinate debenturers common stock currently file security exchange commission close public offer company expect secure institutional finance increase total million dollar private formulation primarily engage manufacture distribution vitamin private label overthecounter pharmaceutical product 
